The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
April 30th 2025
Biomarker testing transforms non-small cell lung cancer treatment, enhancing outcomes through targeted therapies and next-generation sequencing for better patient care.
FDA Approves Treatment for Hemophilia A
August 31st 2018Officials with the FDA have approved Bayer’s antihemophilic factor [recombinant] PEGylated-aucl, BAY94-9027 (Jivi), for the routine prophylactic treatment of hemophilia A in previously treated adults and adolescents 12 years of age or older
Read More
Serious Health Risks Linked to Foods Containing Liquid Nitrogen Added Immediately Before Consumption
August 30th 2018Food products prepared by adding liquid nitrogen at the point of sale, immediately before consumption, have the potential for serious injury, and the FDA is advising consumers to avoid eating, drinking, or handling these products.
Read More
Dozens of Drug Products Recalled Due to Microbial Contamination
August 29th 2018The pet products included in the recall—sold to both consumers and veterinary professionals—are marketed for a variety of uses, including urinary incontinence, anxiety, arthritis, and digestion relief.
Read More
CDC: More Adolescents Receiving HPV Vaccination, But Improvement Needed
August 29th 2018Recent data show that more adolescents are starting and completing the series of HPV vaccinations meant to prevent cervical cancer. Despite the incease in immunizations, some forms of cancers caused by HPV are rising.
Read More
FDA Approves Eravacycline for Adults With Complicated Intra-Abdominal Infections
August 28th 2018Officials with the FDA have approved eravacycline (XERAVA, Tetraphase Pharmaceuticals), a fluorocycline antibacterial within the tetracycline class of antibacterial drugs, for the treatment of complicated intra-abdominal infections (cIAI) in patients aged 18 years and older.
Read More
Trial Results Confirm Aspirin Prevents Primary Vascular Events in Patients With Diabetes
August 27th 2018Serious vascular events in patients with diabetes can be prevented with aspirin use, according to results of the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial, which were presented at the ESC Congress in Munich, Germany.
Read More
ARRIVE Trial: Daily Aspirin Did Not Lower First Heart Attack, Stroke Risk
August 27th 2018The benefits of taking aspirin to prevent a second or subsequent cardiovascular event have been well established in previous studies but the effectiveness of taking aspirin to prevent a first cardiovascular event has been unclear, despite 30 years of randomized clinical trials.
Read More